Cell Marque

Cell Marque is a long-established, private player in the tissue diagnostics market, focusing on immunohistochemistry (IHC) reagents. The company provides a critical toolkit for pathologists and researchers, enabling the visualization of specific cellular markers in tissue samples for disease diagnosis and research. Its business model is centered on the sale of diagnostic antibodies and detection kits, positioning it as a revenue-generating supplier within the broader pathology laboratory ecosystem. While not a therapeutic developer, its products are integral to the diagnostic workflow in oncology, neurology, and other disease areas.

Development and manufacturing of optimized monoclonal and polyclonal antibodies, along with complete detection systems, for immunohistochemistry (IHC) used in clinical pathology and research.

Cell Marque competes in a crowded IHC reagent market dominated by large players like Roche, Agilent (Dako), and Leica Biosystems, which offer integrated staining platforms and reagents. Its competitive strategy relies on product quality, specialized antibody offerings, and strong technical support for clinical laboratories rather than scale.